Startups
The future of drug discovery runs on DaltonTx. Our AI-enabled platforms give pharma, biotech, and CROs the infrastructure modern R&D canât move forward â¨without â transforming the economics, timelines, and outcomes of discovery.
Overview
Location
United Kingdom
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 23, 2025 | DaltonTx lands £4M to advance the intelligence backbone of drug discovery | UK-based technology company DaltonTx has exited stealth and completed a £4 million seed financing round. Backed by Redalpine, IQ Capital Partners, and Seedcamp, with additional support from Oxford University Innovation, DaltonTx will use th... |
| Sep 23, 2025 | DaltonTx Raises £4M in Seed Financing | DaltonTx, a London, UK-based provider of a disease- and technology-agnostic adaptive platform, raised £4M in Seed funding. Backers included redalpine, IQ Capital Partners, and Seedcamp, and support from Oxford University Innovation. The com... |
| DaltonTx | “The future of drug discovery runs on DaltonTx. Our AI-enabled platforms give pharma, biotech, and CROs the infrastructure modern R&D can’t move forward without — transforming the economics, timelines, and outcomes of discovery.”... |
Reviews 0
FAQ about DaltonTx
What has the press written about DaltonTx?
Parsers VC has collected 4 articles mentioning DaltonTx, among them “DaltonTx lands £4M to advance the intelligence backbone of drug discovery” (Sep 23, 2025) and “DaltonTx Raises £4M in Seed Financing” (Sep 23, 2025).
Is DaltonTx still active?
Yes, DaltonTx is active; its latest activity on Parsers VC dates from May 4, 2026.